High EYA2 level has been demonstrated to be a negative element for prognosis in lung cancer (16), while EYA2 predicted better clinical outcomes in colorectal cancer (15) and pancreatic cancer (21). The gene discussed is EYA2; the disease is pancreatic neoplasm.